There is evidence that resistin serum levels in RA patients are positively correlated with inflammatory markers, such as erythrocyte sedimentation rate (ESR) and CRP levels, as well as with the degree of disease activity measured by DAS28 [113,155,160]. The gene discussed is RETN; the disease is rheumatoid arthritis.